BeOne Medicines CEO John Oyler reports disposal of shares worth $75.72 million

• BeOne Medicines CEO John Oyler reported sales totaling 260,359 American Depositary Shares on July 15-16 at prices near USD 310-324.
• Oyler also exercised stock options for 283,154 American Depositary Shares on July 15-16 at prices of USD 100.04, USD 119.96, USD 160.40, USD 169.58.
• He ended July 16 with 0 American Depositary Shares held directly.
• Direct holdings included 5,445,917 ordinary shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BeOne Medicines AG published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001042047-26-000014), on July 17, 2026, and is solely responsible for the information contained therein.